state insights
white papers
media room
blog
subscribe
Does China has what it takes to become a biotech giant ?
Backed by strong government support and heavy private equity investment, the Chinese Biotech industry is booming. But for how long? Can this growth be sustained?
China's biotech 'Long march'
In 2003, the Chinese biotech market was valued at USD 3 billion. It is projected to reach USD 9 billion by 2010. Time to shift R&D biotech centers to China?
Do you know what your Asia competitors are up to ?
In Asia, published information is scarce, competitive intelligence helps you predict your business rival's next move, anticipate marketplace changes and discover new opportunities.
Asia's medical technology hub
In Singapore, the medical technology (medtech) sector accounts for only about 11.8% (S$2.0 billion in 2004) of total Biomedical Science (BMS) output. Despite the low base, the medtech sector has shown tremendous growth potential. For the first half of 2005, medtech manufacturing has outperformed BMS overall, with medtech output growth of 11.5% year-on-year, as compared to 7.7% contraction in overall BMS output.
Medical tourism Asia Pacific: Singapore needs to provide quality to draw foreign patients
In an environment where competition is no longer regional but global, Singapore needs to focus on high-end quality care if it wants to attract affluent patient to the island state for healthcare treatment.
Damien Duhamel is quoted by Singapore's Business Times
Healthcare Tourism in Thailand: Pain ahead?
This article written by Ivy Teh, Managing Director, Clearstate, appeared in the October 15, 2007 issue of Asia Pacific Biotech News Vol. 11 No. 19
bridging intelligence gaps in Healthcare
© Copyright 2006 Clearstate Pte Ltd All Rights Reserved.
Legal Disclaimer
